BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 16548246)

  • 1. [Waldenström's macroglobulinemia].
    Brouet JC
    Rev Prat; 2006 Jan; 56(1):25-30. PubMed ID: 16548246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Waldenström's macroglobulinemia.
    Dimopoulos MA; Anagnostopoulos A
    Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
    Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis and treatment of Waldenström's macroglobulinemia.
    Louw VJ; Webb MJ
    Transfus Apher Sci; 2010 Apr; 42(2):193-7. PubMed ID: 20117052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the treatment of Waldenström's macroglobulinemia.
    Johnson SA
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):329-34. PubMed ID: 16503850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waldenstrom's macroglobulinemia.
    Singhal N; Bapsy PP; Babu KG; Sahoo TP
    J Assoc Physicians India; 2004 Dec; 52():981-5. PubMed ID: 15884458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of Waldenstrom's macroglobulinemia.
    Dimopoulos MA; Kyle RA; Anagnostopoulos A; Treon SP
    J Clin Oncol; 2005 Mar; 23(7):1564-77. PubMed ID: 15735132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waldenström's macroglobulinemia. An overview of its clinical, biochemical, immunological and therapeutic features and our series of 121 patients collected in a single center.
    Merchionne F; Procaccio P; Dammacco F
    Crit Rev Oncol Hematol; 2011 Oct; 80(1):87-99. PubMed ID: 21036057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How we treat Waldenström's macroglobulinemia.
    Dimopoulos MA; Merlini G; Leblond V; Anagnostopoulos A; Alexanian R
    Haematologica; 2005 Jan; 90(1):117-25. PubMed ID: 15642678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waldenström's macroglobulinemia.
    Dimopoulos MA; Galani E; Matsouka C
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1351-66. PubMed ID: 10626154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous Waldenström's macroglobulinemia].
    Mantoux F; Castanet J; Perrin C; Fuzibet JG; Lacour JP; Ortonne JP
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):53-5. PubMed ID: 11937931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of Waldenstrom's macroglobulinemia.
    McDermott MK; Bell EM
    Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waldenström's macroglobulinemia as a diagnostic challenge: case report.
    Budimir I; Nikolić M; Pusić MS; Hrabar D; Ljubicić N; Duvnjak M; Supanc V; Nikolac I; Babić N; Sokcević M
    Acta Clin Croat; 2014 Mar; 53(1):94-7. PubMed ID: 24974671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waldenström's macroglobulinemia: clinical features, complications, and management.
    Dimopoulos MA; Panayiotidis P; Moulopoulos LA; Sfikakis P; Dalakas M
    J Clin Oncol; 2000 Jan; 18(1):214-26. PubMed ID: 10623712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Waldemström s macroglobulinemia].
    Khosravi Shahi P; del Castillo Rueda A; Díaz Muñoz de la Espada VM
    An Med Interna; 2006 Jun; 23(6):291-3. PubMed ID: 17067225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of Waldenström macroglobulinemia and the therapy of diseases caused by monoclonal IgM gammaglobulin].
    Adam Z; Scudla V; Krejcí M; Korístek Z
    Vnitr Lek; 2008 Jan; 54(1):68-83. PubMed ID: 18390120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
    Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.